D-599-2013 Class III Terminated
FDA drug recall D-599-2013 was initiated by Actavis on Jun 3, 2013 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications The recall status is terminated (terminated Apr 9, 2014). Affected quantity: 98,952 boxes.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 19, 2013
- Initiation Date
- Jun 3, 2013
- Termination Date
- Apr 9, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 98,952 boxes
Product description
Fentanyl Transdermal System, 50 mcg/h, 1 system per pouch (NDC 0591-3212-54), packaged in 5-count systems per box (NDC 0591-3212-72), Rx only, Manufactured by Watson Laboratories, Inc, Corona, CA, 92880 USA; Distributed by: Watson Pharma, Inc.
Reason for recall
Failed Impurities/Degradation Specifications
Distribution pattern
Nationwide
Code information
Lot #: Patch 453658; Carton 453658A, Exp 09/13
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-599-2013
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026